Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 8.71%244.21M | 15.51%234.92M | 64.46%247.48M | 42.68%881.25M | 75.02%293.29M | 22.13%224.65M | 14.54%203.37M | 69.92%150.48M | 42.98%617.64M | 167.57M |
| Cost of revenue | 42.96%569.64M | 18.57%398.47M | ||||||||
| Gross profit | 42.18%311.61M | 128.50%219.17M | ||||||||
| Operating expense | 20.86%208.59M | 15.79%202.46M | 65.01%218.12M | 20.87%147.03M | 66.30%227.47M | 13.63%172.59M | 18.78%174.86M | 55.20%132.19M | 186.36%121.64M | 136.78M |
| Selling and administrative expenses | ---- | ---- | ---- | 38.89%159.9M | ---- | ---- | ---- | ---- | 84.11%115.13M | ---- |
| -Selling and marketing expense | ---- | ---- | ---- | 57.36%6.31M | ---- | ---- | ---- | ---- | 23.27%4.01M | ---- |
| -General and administrative expense | ---- | ---- | ---- | 38.22%153.59M | ---- | ---- | ---- | ---- | 87.45%111.12M | ---- |
| Other operating expenses | 16.23%210.05M | 16.07%205.7M | 68.28%225.3M | -59.75%8.45M | 72.40%240.12M | 17.71%180.72M | 12.92%177.22M | 53.22%133.89M | 58.13%20.99M | --139.28M |
| Total other operating income | -81.97%1.47M | 37.05%3.24M | 321.84%7.18M | 47.31%21.32M | 406.00%12.65M | 395.79%8.13M | -75.69%2.37M | -22.87%1.7M | -56.57%14.48M | --2.5M |
| Operating profit | -31.57%35.62M | 13.84%32.46M | 60.50%29.36M | 68.76%164.59M | 113.78%65.83M | 62.35%52.06M | -6.05%28.52M | 439.91%18.29M | 82.51%97.53M | 30.79M |
| Net non-operating interest income (expenses) | 2.88%-4.56M | 19.94%-4.52M | 9.31%-4.77M | -0.70%-15.78M | -3.15%-4.26M | 11.80%-4.69M | -33.45%-5.64M | -45.70%-5.25M | -219.88%-15.67M | -4.13M |
| Non-operating interest income | ---- | ---- | ---- | 87.69%3.02M | ---- | ---- | ---- | ---- | --1.61M | ---- |
| Non-operating interest expense | -2.88%4.56M | -19.94%4.52M | -9.31%4.77M | 8.79%18.8M | 3.15%4.26M | -11.80%4.69M | 33.45%5.64M | 45.70%5.25M | 252.70%17.28M | --4.13M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 87.68%1.58M | 33.73%3.37M | 3,309.54%8.22M | -32.91%8.8M | 254.54%5.19M | -64.77%844K | -51.43%2.52M | -94.19%241K | 244.12%13.12M | 1.47M |
| Special income (charges) | 35.71%-1.63M | -33.88%-2.54M | ||||||||
| Less:Write off | ---- | ---- | ---- | -35.71%1.63M | ---- | ---- | ---- | ---- | 33.88%2.54M | ---- |
| Other non-operating income (expenses) | ||||||||||
| Income before tax | -32.27%32.65M | 23.32%31.32M | 147.08%32.81M | 68.74%155.98M | 137.34%66.77M | 65.44%48.21M | -18.90%25.4M | 237.63%13.28M | 83.21%92.44M | 28.13M |
| Income tax | -17.70%7.94M | 8.03%7.47M | 63.55%6.78M | 46.26%33.44M | 27.07%11.9M | 38.70%9.65M | 31.11%6.92M | 226.89%4.15M | 73.17%22.86M | 9.37M |
| Net income | -35.92%24.71M | 29.04%23.85M | 184.99%26.03M | 76.13%122.54M | 192.38%54.86M | 73.82%38.56M | -29.03%18.48M | 242.74%9.13M | 86.77%69.57M | 18.76M |
| Net income continuous operations | -35.92%24.71M | 29.04%23.85M | 184.99%26.03M | 76.13%122.54M | 192.38%54.86M | 73.82%38.56M | -29.03%18.48M | 242.74%9.13M | 86.77%69.57M | --18.76M |
| Noncontrolling interests | -16.40%8.57M | -31.51%5.5M | 120.26%8.5M | 94.17%37.7M | 183.77%15.46M | 26.95%10.25M | 49.10%8.04M | 670.26%3.86M | 615.06%19.41M | 5.45M |
| Net income attributable to the company | -42.99%16.14M | 75.61%18.35M | 232.34%17.53M | 69.15%84.84M | 195.90%39.4M | 100.64%28.31M | -49.42%10.45M | 143.76%5.28M | 45.23%50.16M | 13.32M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -42.99%16.14M | 75.61%18.35M | 232.34%17.53M | 69.15%84.84M | 195.90%39.4M | 100.64%28.31M | -49.42%10.45M | 143.76%5.28M | 45.23%50.16M | 13.32M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -44.44%0.025 | 75.00%0.028 | 250.00%0.028 | 61.73%0.131 | 195.24%0.062 | 104.55%0.045 | -51.52%0.016 | 128.57%0.008 | 32.79%0.081 | 0.021 |
| Diluted earnings per share | -44.44%0.025 | 75.00%0.028 | 250.00%0.028 | 61.73%0.131 | 195.24%0.062 | 104.55%0.045 | -51.52%0.016 | 128.57%0.008 | 32.79%0.081 | 0.021 |
| Dividend per share | 0 | 0 | 0.04 | 0.07 | 0.03 | 0 | 0.04 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.